Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the ...
Q2 2026
May 13, 2026
Q1 2026
Feb 11, 2026
FY 2025
Nov 19, 2025
Q4 2025
Q3 2025
Aug 13, 2025
